The efficacy of nebulized sodium nitrite ( AIR001 ) has been demonstrated in animal models of pulmonary arterial hypertension ( PAH ) , but it was not known if inhaled nitrite would be well tolerated in human subjects at exposure levels associated with efficacy in these models .